《SSRN,3月9日,Feverish Stock Price Reactions to the Novel Coronavirus》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-03-10
  • Feverish Stock Price Reactions to the Novel Coronavirus

    35 Pages Posted: 9 Mar 2020

    Stefano Ramelli

    University of Zurich - Department of Banking and Finance

    Alexander F. Wagner

    University of Zurich - Department of Banking and Finance; Centre for Economic Policy Research (CEPR); European Corporate Governance Institute (ECGI); Swiss Finance Institute

    Date Written: March 6, 2020

    Abstract

    This paper studies how markets adjust to the sudden and rapid emergence of previously neglected risks. It does so by analyzing the stock price effects of the 2019 novel Coronavirus (COVID-19) outbreak. In the last week of February 2020, many markets fell by 10% or more. The first week of March saw extreme levels of volatility worldwide. However, before these feverish whipsaw movements, we find that the market responded in a relatively orderly fashion by weighting the economic consequences of the evolving outbreak. Over the first two months of 2020, the health care industry did relatively well in China, the US, and several other countries. Transportation and Energy plummeted everywhere. Within industries, US stocks strongly exposed to the China supply chain and those with a strong export orientation towards China suffered.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3550274
相关报告
  • 《JAMA,3月9日,Diagnostic Testing for the Novel Coronavirus》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-11
    • Diagnostic Testing for the Novel Coronavirus Joshua M. Sharfstein, MD1; Scott J. Becker, MS2; Michelle M. Mello, JD, PhD3 Author Affiliations Article Information JAMA. Published online March 9, 2020. doi:10.1001/jama.2020.3864 Controversies over diagnostic testing have dominated US headlines about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus responsible for coronavirus disease 2019 (COVID-19). Technical challenges with the first test developed by the Centers for Disease Control and Prevention (CDC) left the nation with minimal diagnostic capacity during the first few weeks of the epidemic. The CDC also initially limited access to testing to a narrow group of individuals with known exposure. The delayed discovery of a case of COVID-19 in California, followed quickly by evidence of community transmission in multiple states, revealed the shortcomings of this strategy. In the early stages, COVID-19 has spread beyond the nation’s ability to detect it.
  • 《SSRN,3月10日,Characteristics of Respiratory Virus Infection During the Outbreak of 2019 Novel Coronavirus in Beijing》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-11
    • Characteristics of Respiratory Virus Infection During the Outbreak of 2019 Novel Coronavirus in Beijing 20 Pages Posted: 10 Mar 2020 Yan Li Chinese Academy of Medical Sciences - Department of Emergency Medicine Jiangshan Wang Chinese Academy of Medical Sciences - Department of Emergency Medicine Abstract Background: 2019 novel coronavirus (2019-nCoV) is spreading in China and the disease was named as COVID-19, short for “coronavirus disease 2019”. However, other respiratory viruses also cause similar symptoms as COVID-19 does. Here, we summarized the composition of pathogens in fever clinic patients and analyzed characteristics of different respiratory viruses infection. Methods: Retrospectively collected patients with definite etiological results using nasal and pharyngeal swabs in fever clinic. Epidemiologic features, clinical presentation, laboratory findings and image features were collected and analyzed.